Your browser is no longer supported. Please, upgrade your browser.
Settings
CHRS Coherus BioSciences, Inc. daily Stock Chart
CHRS [NASD]
Coherus BioSciences, Inc.
Index- P/E- EPS (ttm)-1.66 Insider Own0.20% Shs Outstand66.01M Perf Week7.62%
Market Cap1.44B Forward P/E9.98 EPS next Y2.18 Insider Trans-87.86% Shs Float64.28M Perf Month-0.82%
Income-117.80M PEG- EPS next Q0.51 Inst Own98.40% Short Float13.60% Perf Quarter-0.14%
Sales120.50M P/S11.91 EPS this Y28.20% Inst Trans-2.26% Short Ratio8.39 Perf Half Y51.82%
Book/sh-0.06 P/B- EPS next Y72.04% ROA-70.60% Target Price31.71 Perf Year31.76%
Cash/sh1.70 P/C12.82 EPS next 5Y23.00% ROE686.10% 52W Range8.32 - 23.43 Perf YTD140.22%
Dividend- P/FCF- EPS past 5Y-14.00% ROI- 52W High-7.21% Beta2.91
Dividend %- Quick Ratio3.30 Sales past 5Y- Gross Margin97.70% 52W Low161.30% ATR1.02
Employees257 Current Ratio3.40 Sales Q/Q- Oper. Margin-88.50% RSI (14)60.50 Volatility5.81% 4.71%
OptionableYes Debt/Eq- EPS Q/Q147.30% Profit Margin-97.80% Rel Volume1.84 Prev Close20.57
ShortableYes LT Debt/Eq- EarningsOct 31 AMC Payout- Avg Volume1.04M Price21.74
Recom1.70 SMA203.17% SMA5011.22% SMA20035.01% Volume1,919,741 Change5.69%
Aug-13-19Initiated Mizuho Buy
Aug-02-19Reiterated Maxim Group Buy $25 → $27
Aug-02-19Reiterated H.C. Wainwright Buy $28 → $29
Jun-11-19Initiated Barclays Overweight $30
May-07-19Initiated H.C. Wainwright Buy $28
Aug-28-18Initiated H.C. Wainwright Buy $28
Mar-09-18Reiterated Maxim Group Buy $20 → $15
Aug-08-17Reiterated JP Morgan Overweight $32 → $25
Jun-13-17Reiterated Maxim Group Buy $44 → $40
May-05-17Initiated BMO Capital Markets Outperform $54
Oct-19-16Initiated Robert W. Baird Outperform $40
Sep-07-16Initiated Maxim Group Buy $43
Jul-27-16Initiated Citigroup Buy $36
Jan-20-16Initiated Credit Suisse Outperform
Sep-20-19 09:30AM  Coherus BioSciences Announces New Employment Inducement Grants GlobeNewswire +5.69%
Sep-13-19 05:10PM  Breakout Stocks & Technical Analysis Investor's Business Daily
Sep-10-19 03:18PM  Investors Can Find Big Returns with this First Profit Screen Zacks
09:00AM  Coherus BioSciences (CHRS) Upgraded to Buy: Here's What You Should Know Zacks
Sep-04-19 11:51AM  Edited Transcript of CHRS earnings conference call or presentation 1-Aug-19 8:30pm GMT Thomson Reuters StreetEvents
Aug-28-19 04:05PM  Stocks To Watch: Is Biosimilars Leader Coherus Biosciences Set To Rebound? Investor's Business Daily
Aug-22-19 09:30AM  Coherus BioSciences Announces New Employment Inducement Grants GlobeNewswire
09:11AM  Is Coherus BioSciences (NASDAQ:CHRS) Using Too Much Debt? Simply Wall St.
Aug-21-19 09:30AM  Coherus BioSciences Management to Present at Two Investor Healthcare Conferences in September GlobeNewswire +9.22%
Aug-01-19 07:52PM  Coherus BioSciences, Inc. (CHRS) Q2 2019 Earnings Call Transcript Motley Fool
06:55PM  Coherus BioSciences (CHRS) Beats Q2 Earnings and Revenue Estimates Zacks
04:00PM  Coherus BioSciences Reports Corporate Highlights and Second Quarter 2019 Financial Results GlobeNewswire
Jul-31-19 01:48PM  Steven Cohen Charges Into Chiasma GuruFocus.com
Jul-29-19 08:30PM  Coherus BioSciences Reports Victory in Pegfilgrastim Patent Dispute GlobeNewswire
Jul-19-19 09:30AM  Coherus BioSciences Announces New Employment Inducement Grants GlobeNewswire
Jul-12-19 12:13PM  Top Ranked Momentum Stocks to Buy for July 12th Zacks
Jul-08-19 04:51PM  Why Deutsche Bank, Intra-Cellular Therapies, and Coherus BioSciences Slumped Today Motley Fool -13.30%
01:30PM  Here's Why Coherus BioSciences Is Falling Today Motley Fool
10:44AM  Are Investors Undervaluing Coherus BioSciences, Inc. (NASDAQ:CHRS) By 20%? Simply Wall St.
09:30AM  Coherus BioSciences Announces Unaudited Second Quarter 2019 UDENYCA® Net Sales of $79 Million to $84 Million GlobeNewswire
09:00AM  Coherus BioSciences to Report Second Quarter Financial Results on August 1st GlobeNewswire
Jul-01-19 09:30AM  Coherus BioSciences Production Exceeds Four-Hundred Thousand UDENYCA® (pegfilgrastim-cbqv) Pre-Filled Syringes GlobeNewswire
Jun-27-19 09:00AM  Coherus BioSciences (CHRS) Upgraded to Strong Buy: Here's Why Zacks
Jun-21-19 09:30AM  Coherus BioSciences Announces New Employment Inducement Grants GlobeNewswire
Jun-14-19 05:59PM  Hedge Funds Have Never Been This Bullish On Coherus Biosciences Inc (CHRS) Insider Monkey
May-23-19 10:38AM  Amgen (AMGN) Offers to Acquire Drug Discovery Platform Zacks
09:30AM  Coherus BioSciences Announces New Employment Inducement Grants GlobeNewswire
May-22-19 09:55AM  Did Coherus BioSciences's (NASDAQ:CHRS) Share Price Deserve to Gain 29%? Simply Wall St.
09:30AM  Coherus BioSciences Management to Present at Jefferies 2019 Global Healthcare Conference GlobeNewswire
May-21-19 10:51PM  Edited Transcript of CHRS earnings conference call or presentation 9-May-19 8:30pm GMT Thomson Reuters StreetEvents
May-13-19 11:30AM  2 Drug Stocks to Buy as Health Care Suffers, According to JPMorgan Barrons.com
May-09-19 07:54PM  Coherus BioSciences, Inc. (CHRS) Q1 2019 Earnings Call Transcript Motley Fool
05:35PM  Coherus BioSciences (CHRS) Reports Q1 Loss, Tops Revenue Estimates Zacks
04:24PM  Coherus BioSciences: 1Q Earnings Snapshot Associated Press
04:01PM  Coherus BioSciences Reports Corporate Highlights and First Quarter 2019 Financial Results GlobeNewswire
May-08-19 04:04PM  Did Hedge Funds Drop The Ball On Coherus Biosciences Inc (CHRS) ? Insider Monkey
May-02-19 05:00PM  Coherus BioSciences and Amgen Settle Trade Secrets Action GlobeNewswire
09:30AM  Coherus BioSciences Management to Present at Two Upcoming Investor Healthcare Conferences GlobeNewswire
Apr-26-19 06:58AM  Moving Average Crossover Alert: Coherus BioSciences Zacks
Apr-25-19 09:27AM  The Zacks Analyst Blog Highlights: Incyte, Aduro Biotech, MeiraGTx and Coherus BioSciences Zacks
Apr-24-19 09:11AM  5 Biotech Stocks Defying the Medicare-for-All Scare Zacks
Apr-19-19 09:30AM  Coherus BioSciences Announces New Employment Inducement Grants GlobeNewswire
Apr-09-19 08:41AM  Coherus (CHRS) Catches Eye: Stock Jumps 6.9% Zacks -5.87%
Apr-08-19 04:32PM  Why Sony, AMC Entertainment Holdings, and Coherus BioSciences Jumped Today Motley Fool +6.90%
01:04PM  Here's Why Coherus BioSciences Popped Today Motley Fool
Apr-07-19 09:27AM  Read This Before Buying Coherus BioSciences, Inc. (NASDAQ:CHRS) Shares Simply Wall St.
Apr-05-19 04:00PM  Coherus BioSciences Announces Unaudited First Quarter 2019 UDENYCA Net Sales GlobeNewswire
08:30AM  Coherus BioSciences to Report First Quarter Financial Results on May 9th GlobeNewswire
Mar-28-19 09:30AM  Coherus BioSciences Management to Present at H.C. Wainwright & Co. Global Life Sciences Conference GlobeNewswire
Mar-22-19 09:30AM  Coherus BioSciences Announces New Employment Inducement Grants GlobeNewswire -7.61%
Mar-19-19 09:30AM  Coherus BioSciences Announces New Employment Inducement Grants GlobeNewswire
Mar-18-19 09:30AM  Coherus BioSciences Appoints Thomas Fitzpatrick Chief Legal Officer GlobeNewswire
Mar-05-19 08:24PM  Edited Transcript of CHRS earnings conference call or presentation 28-Feb-19 9:30pm GMT Thomson Reuters StreetEvents
08:30AM  New Research: Key Drivers of Growth for American Tower Corporation (REIT), Lowe's Companies, Mimecast, Live Nation Entertainment, Intercept Pharmaceuticals, and Coherus BioSciences Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire
Feb-28-19 07:10PM  Coherus BioSciences Inc (CHRS) Q4 2018 Earnings Conference Call Transcript Motley Fool
04:30PM  Coherus BioSciences Reports Fourth Quarter and Full Year 2018 Financial Results GlobeNewswire
Feb-26-19 09:30AM  Coherus BioSciences Management to Present at Two Investor Healthcare Conferences in March GlobeNewswire -6.55%
Feb-22-19 09:30AM  Coherus BioSciences Announces New Employment Inducement Grants GlobeNewswire
Feb-14-19 09:30AM  Coherus BioSciences to Report Fourth Quarter and Full Year 2018 Financial Results on February 28th GlobeNewswire
Feb-11-19 02:46PM  Here's Why Coherus BioSciences Rose 48.7% in January Motley Fool
Feb-07-19 09:30AM  Coherus BioSciences Announces New Employment Inducement Grants GlobeNewswire
Jan-25-19 12:00PM  Coherus BioSciences Announces Filing of Patent Infringement Suit Against Amgen Directed to Amgens Humira Biosimilar Formulation GlobeNewswire +6.54%
08:00AM  Coherus BioSciences Announces Global Settlement with AbbVie Securing Rights to Commercialize its Adalimumab Biosimilar Candidate, CHS-1420 GlobeNewswire
Jan-18-19 09:30AM  Coherus BioSciences Announces New Employment Inducement Grants GlobeNewswire +5.49%
Jan-15-19 11:03AM  Coherus BioSciences, Inc. (NASDAQ:CHRS) Is Expected To Breakeven Simply Wall St.
Jan-14-19 09:30AM  Coherus BioSciences Announces New Employment Inducement Grants GlobeNewswire
Jan-07-19 09:25AM  Coherus BioSciences Secures $75 Million Credit Financing with HealthCare Royalty Partners GlobeNewswire +18.22%
Jan-02-19 09:30AM  Coherus BioSciences Management to Present at The 37th Annual J.P. Morgan Healthcare Conference GlobeNewswire
Dec-21-18 10:53AM  Edited Transcript of CHRS earnings conference call or presentation 8-Nov-18 9:30pm GMT Thomson Reuters StreetEvents -7.98%
Dec-19-18 09:30AM  Coherus BioSciences Announces New Employment Inducement Grants GlobeNewswire
Dec-13-18 01:36AM  Edited Transcript of CHRS earnings conference call or presentation 10-May-18 8:30pm GMT Thomson Reuters StreetEvents
Dec-12-18 12:13AM  Should You Buy Coherus Biosciences Inc (CHRS)? Insider Monkey
Dec-03-18 07:40AM  Investor Expectations to Drive Momentum within Virtu Financial, Fate Therapeutics, Tandem Diabetes Care, Eli Lilly, Griffon, and Coherus BioSciences Discovering Underlying Factors of Influence GlobeNewswire
Nov-30-18 09:30AM  Coherus BioSciences Announces Apexus Contract Agreement for 340B Hospitals and Clinics, and Q-Code Issuance from CMS GlobeNewswire
Nov-29-18 07:52AM  Coherus BioSciences (CHRS): Moving Average Crossover Alert Zacks
Nov-27-18 06:00PM  Coherus BioSciences Announces New Employment Inducement Grants GlobeNewswire -5.79%
Nov-16-18 10:20AM  Is Coherus BioSciences Incs (NASDAQ:CHRS) CEO Paid Enough Relative To Peers? Simply Wall St.
Nov-12-18 08:00AM  Coherus BioSciences Management to Present at the 27th Annual Credit Suisse Healthcare Conference GlobeNewswire +8.85%
Nov-08-18 05:03PM  Coherus prices biosimilar to Amgen's Neulasta at 33 pct discount Reuters
05:02PM  Coherus BioSciences: 3Q Earnings Snapshot Associated Press
04:01PM  Coherus BioSciences Reports Corporate Highlights and Third Quarter 2018 Financial Results GlobeNewswire
Nov-02-18 01:41PM  U.S. FDA Approves UDENYCA (pegfilgrastim-cbqv) GlobeNewswire +6.03%
Oct-24-18 09:15AM  New Research: Key Drivers of Growth for UnitedHealth Group, The Wendy's Co., Xenia Hotels & Resorts, TopBuild, Coherus BioSciences, and Virtu Financial Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire -10.09%
Oct-22-18 08:00AM  Coherus BioSciences to Report Third Quarter 2018 Financial Results on November 8th GlobeNewswire
Oct-11-18 03:02PM  Here's Why Coherus BioSciences Fell 18.1% in September Motley Fool
Oct-09-18 08:00AM  Coherus BioSciences Announces New Employment Inducement Grants GlobeNewswire
Sep-26-18 12:32PM  Amgen's Neulasta Has a New Competitor in Europe GuruFocus.com
Sep-25-18 01:38PM  Coherus BioSciences Receives European Commission Approval for UDENYCA (Pegfilgrastim Biosimilar) GlobeNewswire
Sep-21-18 08:00AM  Coherus BioSciences Announces New Employment Inducement Grants GlobeNewswire
Sep-17-18 08:00AM  Coherus BioSciences Management to Present at the 2018 Cantor Global Healthcare Conference in October GlobeNewswire
Sep-12-18 12:27PM  Edited Transcript of CHRS earnings conference call or presentation 8-Aug-18 8:30pm GMT Thomson Reuters StreetEvents
Aug-31-18 07:50AM  Research Report Identifies Holly Energy Partners, First Merchants, Enbridge Energy Management, Activision Blizzard, Coherus BioSciences, and Kala Pharmaceuticals with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Aug-20-18 08:00AM  Coherus BioSciences Management to Participate in Two Investor Healthcare Conferences in September GlobeNewswire
Aug-17-18 05:30PM  Coherus BioSciences Announces New Employment Inducement Grants GlobeNewswire
Aug-08-18 06:14PM  Coherus BioSciences: 2Q Earnings Snapshot Associated Press
04:01PM  Coherus BioSciences Reports Corporate Highlights and Second Quarter 2018 Financial Results GlobeNewswire
02:30PM  Coherus BioSciences, Inc. to Host Earnings Call ACCESSWIRE
Jul-27-18 09:36AM  Coherus BioSciences Receives Positive CHMP Opinion for UDENYCA (Pegfilgrastim Biosimilar Candidate) GlobeNewswire
08:20AM  Market Trends Toward New Normal in United Technologies, Paychex, Coherus BioSciences, InfraREIT, Cousins Properties, and Engility Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire
Jul-25-18 04:05PM  Coherus BioSciences Announces New Employment Inducement Grants GlobeNewswire
Coherus BioSciences, Inc., a commercial-stage biotherapeutics company, focuses on the biosimilar market worldwide. It markets UDENYCA, a long-acting granulocyte-colony stimulating factor, which stimulates production of granulocytes in order to promote the body's ability to fight infections. The company sells UDENYCA in the United States. Its clinical-stage product candidates include immunology, anti-tumor necrosis factor biosimilar candidates, CHS-1420 for adalimumab and CHS-0214 for etanercept, which has completed Phase III clinical programs; ophthalmology biosimilar candidates, CHS-3351 for ranibizumab and CHS-2020 for aflibercept that is in preclinical development; and CHS-131, small molecule therapeutic candidate and other metabolic conditions. Coherus BioSciences, Inc. has collaboration and license agreements with Daiichi Sankyo Company, Limited; Baxalta Incorporated; Baxalta US Inc.; Baxalta GmbH; and Selexis SA. The company was formerly known as BioGenerics, Inc. and changed its name to Coherus BioSciences, Inc. in April 2012. Coherus BioSciences, Inc. was founded in 2010 and is headquartered in Redwood City, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Viret Jean-FredericChief Financial OfficerSep 18Option Exercise10.053,15931,74811,672Sep 20 04:05 PM
Viret Jean-FredericChief Financial OfficerSep 18Sale20.443,15964,5608,513Sep 20 04:05 PM
Anicetti Vincent RChief Operating OfficerSep 16Option Exercise2.502,5006,25121,810Sep 18 04:05 PM
Anicetti Vincent RChief Operating OfficerSep 16Sale20.032,50050,07519,310Sep 18 04:05 PM
Viret Jean-FredericChief Financial OfficerAug 21Option Exercise10.056,31863,49614,831Aug 23 04:05 PM
Viret Jean-FredericChief Financial OfficerAug 21Sale21.716,318137,1548,513Aug 23 04:05 PM
Viret Jean-FredericChief Financial OfficerAug 19Sale19.043,00057,1208,513Aug 21 04:05 PM
Anicetti Vincent RChief Operating OfficerAug 14Option Exercise2.502,5006,25121,810Aug 16 04:07 PM
Anicetti Vincent RChief Operating OfficerAug 14Sale19.002,50047,50019,310Aug 16 04:07 PM
Anicetti Vincent RChief Operating OfficerJul 15Option Exercise2.502,5006,25121,810Jul 17 04:05 PM
Anicetti Vincent RChief Operating OfficerJul 15Sale19.202,50048,00019,310Jul 17 04:05 PM
HEALY JAMESDirectorJul 02Sale22.61160,0003,617,6001,933,221Jul 02 06:57 PM
HEALY JAMESDirectorJun 28Sale22.05200,0004,410,0002,093,221Jul 02 06:57 PM
HEALY JAMESDirectorJun 20Sale21.37317,1306,777,0682,293,221Jun 24 06:30 PM
Viret Jean-FredericChief Financial OfficerJun 19Option Exercise10.053,15931,74814,672Jun 20 04:05 PM
Viret Jean-FredericChief Financial OfficerJun 19Sale20.283,82677,58711,513Jun 20 04:05 PM
Viret Jean-FredericChief Financial OfficerJun 18Sale19.313,00057,92612,180Jun 20 04:05 PM
Lanfear Dennis MPresident & CEOMay 30Sale19.4932,398631,2821,284,184May 31 08:46 PM
HEALY JAMESDirectorMay 22Sale20.69257,8705,335,3302,610,351May 24 09:44 PM
Viret Jean-FredericChief Financial OfficerMar 20Sale14.923,00044,76213,185Mar 22 04:05 PM